When B12 Isnt Enough: Exploring Alternatives for Energy If youve optimized your B12 regimen and still arent seeing the expected energy boost, it may be time to explore other options
Retatrutide may appeal to individuals seeking: Significant weight reduction Advanced obesity treatment options Enhanced appetite control Comprehensive metabolic support Its triple-receptor mechanism has made it one of the most closely watched developments in obesity medicine
Research news Mouse experiments have suggested that glucagon-like peptide-1 receptor agonists may reduce pulmonary fibrosis following a COVID-19 infection in people with type 2 diabetes, although researchers cautioned that the findings remain preliminary Glucagon-like peptide-1 (GLP-1) receptor agonists, already used to treat type 2 diabetes (T2DM) and obesity, may also help to reduce the risk of COVID-19-related lung scarring in people with T2DM, according to research in mouse models
Fatty Liver: Leads to fatty liver, which can progress to liver dysfunction, cirrhosis, or cancer
Sanjay Bharti, MD , offers GLP-1 therapy for medical weight loss in Fairmont, WV
"That provided enough of a buffer in my stomach to abate the nausea," he says